DIVIS LABORATORIES
Back to Cashflow Statement
|
DIVIS LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-804 Cr | ₹-799 Cr | ₹-799 Cr | ₹-797 Cr | ₹-532 Cr |
What is the latest Cash Flow from Financing Activities ratio of DIVIS LABORATORIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-804 Cr |
| Mar2025 | ₹-799 Cr |
| Mar2024 | ₹-799 Cr |
| Mar2023 | ₹-797 Cr |
| Mar2022 | ₹-532 Cr |
How is Cash Flow from Financing Activities of DIVIS LABORATORIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-804 Cr | Negative | |
| Mar2025 | ₹-799 Cr | Negative | |
| Mar2024 | ₹-799 Cr | Negative | |
| Mar2023 | ₹-797 Cr | Negative | |
| Mar2022 | ₹-532 Cr | - | |
Compare Cash Flow from Financing Activities of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹244,601.2 Cr | -3.3% | -0.2% | 63.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,562.0 Cr | -3.2% | -7.8% | 14.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,871.0 Cr | -2.4% | -5% | 33.6% | Stock Analytics | |
| CIPLA | ₹107,770.0 Cr | -4% | -5.6% | -10.2% | Stock Analytics | |
| MANKIND PHARMA | ₹102,433.0 Cr | 1.7% | 4.2% | 1.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,829.0 Cr | -1.2% | 4.1% | -4.2% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -3.3% |
-0.2% |
63.3% |
| SENSEX | -2.1% |
-5.9% |
-10.8% |
You may also like the below Video Courses